Skip to main content

Hypercholesteremia

4
Pipeline Programs
6
Companies
5
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
2
2
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
2100%
+ 4 programs with unclassified modality

Competitive Landscape

6 companies ranked by most advanced pipeline stage

Shionogi
ShionogiJapan - Osaka
1 program
1
RosuvastatinPhase 4Small Molecule1 trial
Active Trials
NCT00329160Completed214Est. Oct 2008
Astellas
AstellasChina - Shenyang
1 program
1
atorvastatinPhase 4Small Molecule2 trials
Active Trials
NCT00408382Completed50
NCT05404139Recruiting352Est. Feb 2031
MSD
MSDIreland - Ballydine
1 program
1
MK-0524APhase 3
Sharp Therapeutics
Sharp TherapeuticsPA - Pittsburgh
1 program
1
MK-0524APhase 3
Conception
ConceptionCA - Berkeley
1 program
LimicolN/A1 trial
Active Trials
NCT01354327Completed47Est. May 2011
AstraZeneca
AstraZenecaCAMBRIDGE, United Kingdom
1 program
Pattern of Statins Use in CataloniaN/A1 trial
Active Trials
NCT01477944Completed180,723Est. Feb 2012

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
ShionogiRosuvastatin
Astellasatorvastatin
AstraZenecaPattern of Statins Use in Catalonia
ConceptionLimicol

Clinical Trials (5)

Total enrollment: 181,386 patients across 5 trials

NCT00408382Astellasatorvastatin

Lipitor Phase 4 Clinical Trial in Hypercholesteremia Patients With Yellow Coronary Plaque

50 patients
Phase 4Completed
NCT00329160ShionogiRosuvastatin

Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease

Start: Oct 2005Est. completion: Oct 2008214 patients
Phase 4Completed
NCT05404139Astellasatorvastatin

Duration of Androgen Receptor Pathway Inhibitor and ADT With Metastasis Directed Therapy in Oligometastatic Cancer of the Prostate (DIRECT)

Start: May 2023Est. completion: Feb 2031352 patients
Phase 2Recruiting
NCT01477944AstraZenecaPattern of Statins Use in Catalonia

Pattern of Statins Use in Catalonia

Start: Feb 2012Est. completion: Feb 2012180,723 patients
N/ACompleted
NCT01354327ConceptionLimicol

Effects of Limicol on LDL-cholesterol

Start: Dec 2008Est. completion: May 201147 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 late-stage (Phase 3) programs, potential near-term approvals
1 actively recruiting trials targeting 181,386 patients
6 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.